Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies

Abstract After being stagnant for decades, there has finally been a paradigm shift in the treatment of cancer with the emergence and application of immune checkpoint inhibitors (ICIs). The most extensively utilized ICIs are targeting the pathways involving programmed death-1 (PD-1) and cytotoxic T-l...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wenwen Yang, Caining Lei, Shaoming Song, Wutang Jing, Chuanwei Jin, Shiyi Gong, Hongwei Tian, Tiankang Guo
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Accès en ligne:https://doaj.org/article/4737bbfa432544ec8485c334fc35df4d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!